How Colitis Medications Work

Colitis is a type of inflammatory bowel disease (IBD) characterized by chronic inflammation and ulceration of the colon. The primary goal of medication treatment is to reduce inflammation, induce remission, and maintain long-term control.

Gold Standard Treatment: Aminosalicylates

The gold standard for treating mild to moderate colitis is aminosalicylates, such as sulfasalazine. These medications work by:

• Inhibiting the production of pro-inflammatory mediators, which contribute to inflammation and tissue damage.

• Reducing the permeability of the intestinal lining, thereby decreasing the passage of toxins and inflammatory molecules into the bloodstream.

Alternative Treatments: Corticosteroids, Immunomodulators, and Biologics

For moderate to severe colitis or patients who do not respond to aminosalicylates, alternative treatments may be considered. These include:

• Corticosteroids (e.g., prednisone), which suppress the immune system and reduce inflammation.

• Immunomodulators (e.g., azathioprine), which modify the immune response to prevent chronic inflammation.

• Biologics (e.g., infliximab), which target specific molecules involved in inflammation and immune response, such as tumor necrosis factor-alpha (TNF-α).